Targeted metabolomics and medication classification data from participants in the ADNI1 cohort
出版年份 2017 全文链接
标题
Targeted metabolomics and medication classification data from participants in the ADNI1 cohort
作者
关键词
-
出版物
Scientific Data
Volume 4, Issue -, Pages 170140
出版商
Springer Nature
发表日期
2017-10-17
DOI
10.1038/sdata.2017.140
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Blood metabolite markers of preclinical Alzheimer's disease in two longitudinally followed cohorts of older individuals
- (2016) Ramon Casanova et al. Alzheimers & Dementia
- 2016 Alzheimer's disease facts and figures
- (2016) Alzheimers & Dementia
- Interlaboratory Reproducibility of a Targeted Metabolomics Platform for Analysis of Human Serum and Plasma
- (2016) Alexandros P. Siskos et al. ANALYTICAL CHEMISTRY
- Pharmacometabolomics informs pharmacogenomics
- (2016) Drew Neavin et al. Metabolomics
- Impact of the Alzheimer's Disease Neuroimaging Initiative, 2004 to 2014
- (2015) Michael W. Weiner et al. Alzheimers & Dementia
- Alzheimer’s disease cerebrospinal fluid biomarker in cognitively normal subjects
- (2015) Jon B. Toledo et al. BRAIN
- Metabolomic Signatures for Drug Response Phenotypes: Pharmacometabolomics Enables Precision Medicine
- (2015) R Kaddurah-Daouk et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Blood metabolite markers of cognitive performance and brain function in aging
- (2015) Brittany N Simpson et al. JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM
- Plasma 24-metabolite Panel Predicts Preclinical Transition to Clinical Stages of Alzheimer’s Disease
- (2015) Massimo S. Fiandaca et al. Frontiers in Neurology
- From Lost in Translation to Paradise Found: Enabling Protein Biomarker Method Transfer by Mass Spectrometry
- (2014) R. P. Grant et al. CLINICAL CHEMISTRY
- Age-specific population frequencies of cerebral β-amyloidosis and neurodegeneration among people with normal cognitive function aged 50–89 years: a cross-sectional study
- (2014) Clifford R Jack et al. LANCET NEUROLOGY
- Plasma phospholipids identify antecedent memory impairment in older adults
- (2014) Mark Mapstone et al. NATURE MEDICINE
- Contribution of Alzheimer disease to mortality in the United States
- (2014) B. D. James et al. NEUROLOGY
- Pharmacometabolomics: Implications for Clinical Pharmacology and Systems Pharmacology
- (2013) R Kaddurah-Daouk et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Shorthand notation for lipid structures derived from mass spectrometry
- (2013) Gerhard Liebisch et al. JOURNAL OF LIPID RESEARCH
- Metabolomics: the apogee of the omics trilogy
- (2012) Gary J. Patti et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Metabolomics in Early Alzheimer's Disease: Identification of Altered Plasma Sphingolipidome Using Shotgun Lipidomics
- (2011) Xianlin Han et al. PLoS One
- Circulating plasmalogen levels and Alzheimer Disease Assessment Scale–Cognitive scores in Alzheimer patients
- (2010) Paul Wood JOURNAL OF PSYCHIATRY & NEUROSCIENCE
- Isotope correction of mass spectrometry profiles
- (2010) Günther Eibl et al. RAPID COMMUNICATIONS IN MASS SPECTROMETRY
- Alzheimer's Disease Neuroimaging Initiative (ADNI): Clinical characterization
- (2009) R. C. Petersen et al. NEUROLOGY
- Metabolomics: A Global Biochemical Approach to Drug Response and Disease
- (2008) Rima Kaddurah-Daouk et al. Annual Review of Pharmacology and Toxicology
- Metabolomics: A Global Biochemical Approach to the Study of Central Nervous System Diseases
- (2008) Rima Kaddurah-Daouk et al. NEUROPSYCHOPHARMACOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now